2011
DOI: 10.1007/s12291-011-0109-3
|View full text |Cite
|
Sign up to set email alerts
|

Study of Serum Homocysteine, Folic Acid and Vitamin B12 in Patients with Preeclampsia

Abstract: The present study was carried out to evaluate the occurrence of association between homocysteine, folic acid and vitamin B 12 in patients with preeclampsia. Fifty preeclamptic patients from gynecology ward were studied for estimation of serum homocysteine, folic acid and vitamin B 12 over a period of October 2007 to June 2010. Serum homocysteine and folic acid, and vitamin B 12 were determined by means of Immulite 1000 analyzer. The statistical analysis of study group of preeclampsia compared with normotensive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
42
1
3

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(46 citation statements)
references
References 18 publications
0
42
1
3
Order By: Relevance
“…7 Several other studies were in consonance with the present study. 5,6,[8][9][10] On the contrary Zeeman GG et al did not agree with our observations and there was no significant difference in maternal serum levels of homocysteine between pre-eclampsia and normal pregnancy (5.1±1.7 μmol/l vs 4.7±1.3 μmol/l p value =0.56) and they stated that serum homocysteine levels were not helpful in the prediction of PE. 11 Hietala R et al also stated that there was no difference between pre-eclampsia and normotensive women (6.42, 7.55μmol/l vs 6.45, 7.34 μmol/l).…”
Section: Discussioncontrasting
confidence: 97%
“…7 Several other studies were in consonance with the present study. 5,6,[8][9][10] On the contrary Zeeman GG et al did not agree with our observations and there was no significant difference in maternal serum levels of homocysteine between pre-eclampsia and normal pregnancy (5.1±1.7 μmol/l vs 4.7±1.3 μmol/l p value =0.56) and they stated that serum homocysteine levels were not helpful in the prediction of PE. 11 Hietala R et al also stated that there was no difference between pre-eclampsia and normotensive women (6.42, 7.55μmol/l vs 6.45, 7.34 μmol/l).…”
Section: Discussioncontrasting
confidence: 97%
“…[7][8][9]14,26,27 In addition, 2 prospective cohort studies did not observe a lower risk of hypertensive disorders of pregnancy with a greater intake of folate during the first trimester or between 13 and 21 weeks gestation. 28,29 The interest in folic acid for the prevention of cardiovascular disease stems from its critical role in lowering plasma homocysteine, which was found to be associated with a higher risk of cardiovascular disease in epidemiological studies.…”
Section: Discussionmentioning
confidence: 96%
“…30 Many studies in past decades showed that women with gestational hypertension or preeclampsia had a significant elevation of homocysteine postpartum, in the third trimester, in the second trimester, or even in early pregnancy. [5][6][7][8][9][10] Taking into consideration this emerging evidence, in combination with other data implicating hyperhomocysteinemia as an independent risk factor for vascular disease, some researchers hypothesized that hyperhomocysteinemia might be an independent risk factor for gestational hypertension. 6,12 However, recent trials have failed to demonstrate a benefit of lowering homocysteine for cardiovascular disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Повышение уровня гомоцистеина значимо в патогенезе атеросклероза, ише-мической болезни сердца, инсульта, венозного тромбоза, нейродегенеративных заболеваний, остеопоротических переломов [19,20]. Эндотелиальная дисфункция, возни-кающая при гипергомоцистеинемии, является фактором патогенеза осложнений беременности, зависящих от ми-кроциркуляции, начиная с самопроизвольного выкиды-ша в I триместре беременности и заканчивая преэкламп-сией, преждевременной отслойкой плаценты и антена-тальной гибелью плода [21,22].…”
unclassified